scispace - formally typeset
Z

Zhila Izadi

Researcher at Kermanshah University of Medical Sciences

Publications -  32
Citations -  557

Zhila Izadi is an academic researcher from Kermanshah University of Medical Sciences. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 10, co-authored 22 publications receiving 299 citations. Previous affiliations of Zhila Izadi include Royan Institute & Tehran University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

β-lactoglobulin-pectin Nanoparticle-based Oral Drug Delivery System for Potential Treatment of Colon Cancer.

TL;DR: The drug release profile in simulated gastrointestinal conditions demonstrated that β‐lactoglobulin with a secondary coating is stable in acidic conditions but is able to release its cargo at pH 7.5, which indicates these nanoparticles have potential to serve as novel and effective vehicles for oral drug delivery preparations.
Journal ArticleDOI

Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.

TL;DR: Loading curcumin in NLCs is an effective strategy for increasingCurcumin delivery to the brain and reducing Aβ-induced neurological abnormalities and memory defects and that it can be the basis for further studies in the area of AD prevention and treatment.
Journal ArticleDOI

Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug

TL;DR: The results obtained indicated that both the cytotoxicity and cellular uptake of platinum were enhanced by its entrapment in β-CN-CS nanovehicles, suggesting that this novel drug-delivery system enables drugs to be thermodynamically stable in aqueous solutions and is potentially useful for targeted oral-del delivery applications.
Journal ArticleDOI

Biomedical Applications of Zeolitic Nanoparticles, with an Emphasis on Medical Interventions

TL;DR: Light is shed on interactions of zeolite nanoparticles with fibrinogen and amyloid beta which had been comprehensively investigated in recent reports, and the preliminary approaches for deeper understanding of administration, distribution, metabolism and excretion of zeolinic nanoparticles are elucidated.